Vote Now
Research Grants - 2009


Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2009


To view an abstract, select an author from the vertical list on the left.

2009 Grants - Shen

Abnormal APP Processing in Living Cortical Neurons from Alzheimer Brains

Yong Shen, M.D., Ph.D.
The Roskamp Institute Inc
Florida

2009 Investigator-Initiated Research Grant

In the brain, amyloid precursor protein (APP) is cut into pieces, one of which is beta-amyloid. Under some conditions, beta-amyloid aggregates to form amyloid plaque, a hallmark feature of Alzheimer pathology. Because of the central role of APP in the development and progression of disease, the production, processing and cutting of this protein are of great interest. Indeed, these processes are potential targets for therapies to slow or halt disease progression.

Yong Shen, M.D., Ph.D. and colleagues are studying the processing of APP in nerve cells affected by Alzheimer's disease. They have developed the ability to maintain living brain cells from individuals who recently died of Alzheimer's disease. Using these cells, Dr. Shen and colleagues plan to examine the factors affecting the production of beta-amyloid.

The researchers plan to first examine the activity of the Alzheimer nerve cells, using imaging methods and methods to record electrical activity. They expect to see abnormally high activity of these cells compared to cells unaffected by Alzheimer's disease. Next, the researchers will examine whether cellular activity causes increases in the production of beta-amyloid. Finally, they will determine if activity affects the expression of enzymes involved in cutting APP, especially an enzyme known as BACE1 (beta-site amyloid precursor protein-cleaving enzyme-1). These studies will directly examine the cellular effects of Alzheimer's disease in the brain, and they may help to explain the mechanisms of beta-amyloid production and disease progression.